Introduction to Obesity and Diabetes- The windows of opportunity -- Nutrition transition and obesity trends in Argentina within the Latin American context -- Challenges and Economic Burden of Diabetes in Africa -- Brown adipose tissue in obesity and diabetes -- White and Brown Adipose Tissue in Obesity and Diabetes -- microRNAs in obesity and metabolic diseases -- From Adipogenic Viruses to Anti-Diabetic Drug: A Translational Journey -- Genetic profiles in the obese population -- The Upstream Environment for the Obesity Epidemic -- Inflammation and its role in obesity-related complications -- Cross talk between adipose tissue, macrophages and other immune cells: Development of obesity and inflammation-induced metabolic diseases -- Diabetes forecasts and statistics for the coming decades -- Pancreatic islets of Langerhans: adapting cell and molecular biology to changes of metabolism -- Targeting advanced glycation end products (esRAGE and sRAGE) for obesity, diabetes and its associated complications -- Anti-incretin effect: a missing link between obesity, diabetes and metabolic surgery -- An update on Mendelian forms of obesity and their personalized treatments -- The Genetic Basis of Diabetic Kidney Disease -- Epigenetics and chronic inflammation: Role in early detection of type 2 diabetes -- Salivary and Urinary Metabolome in Pediatric Obesity and Metabolic Syndrome -- State-of-the-Art Metabolomics Investigations of Type 2 Diabetes -- The gut microbiome and type 2 diabetes mellitus -- Immunotherapeutic Approach to the Treatment and Prevention of Obesity -- Metabolic Syndrome Update -- Non-alcoholic fatty liver disease: a global public health issue -- Non-Alcoholic Fatty Pancreatic Disease (NAFPD) -- Normal weight obesity - A hidden pandemic -- Obesity in Children/Adolescents and Obesity-Related Comorbidities -- Obesity and cancer: linked molecular mechanisms -- Cognitive impairment in obesity and diabetes -- Metabolic pathways underlying neuropsychiatric disorders and obesity -- Heart failure and the obesity paradox -- Inflammatory mechanisms in diabetic kidney disease -- The epidemiology of the diabetes - depression comorbidity in Brazil -inequality and interaction -- Contribution of Hyperglycemia and Unhealthy Diet to Cardiovascular Mortality -- Gestational Diabetes Mellitus -- Update on Gestational Diabetes -- Vascular complications in type 2 diabetes -- What We Know and Don't about High-Intensity Sweeteners -- Personalised Molecular Feedback for Weight Loss -- Diabetes and Obesity in the Child and Adolescent: Guidelines and Challenges -- Type 2 diabetes - an unresolved disease -- Glucose control in the ICU -- Continuous glucose monitors as wearable lifestyle behavior change tools in obesity and diabetes -- Endoscopic techniques for obesity and diabetes -- Bariatric embolization: a possible non-surgical option for weight reduction -- Progress in noninvasive beta-cell mass imaging -- Cancer staging with 18F-FDG PET/CT in hyperglycemic patients -- Pancreatic Islet Transplantation: A Surgical Approach to Type 1 Diabetes Treatment -- Pancreatic Transplantation in Diabetes: Indications, Contraindications and Perspectives. -Pharmacotherapy of Type 2 Diabetes -- GLP1-Receptor Agonists in Diabetes: Drugs, General Effects, and Cardiovascular Impact -- Diabetes and treatments -- Treatment of Diabetes and Heart Failure -- Cardiovascular impact of newer diabetes medications -- Pathogenesis and Molecular Targets in treatment of Diabetic Wounds -- Efficiency in public health through the promotion of Diabetes Day Hospitals: a regional proposal -- Surgical options in obesity and diabetes -- One anastomosis gastric bypass in the treatment of obesity: effects on body weight and the metabolome -- Robotic bariatric surgery -- The Role of Obesity and Bariatric Surgery in the Management of Knee and Hip Osteoarthritis -- Relapse of diabetes after metabolic/bariatric surgery -- Malnutrition in Obesity -- Sugar-Sweetened Beverage Taxes: Origins, Mechanisms, and Current Worldwide Status -- Mobile Health Interventions for Weight Management in Overweight and Obese Populations -- Biomarkers and Machine Learning Applications in Obesity -- Current approaches in diabetes mellitus prediction: applications of machine learning and emerging biomarkers -- Polycystic ovary syndrome and sarcopenic obesity -- Drug Pipeline for Obesity Therapy -- MC4R as a Target for Pharmacotherapeutic Treatment of Obesity and Type-2 diabetes -- Nanotechnology: Can it be a crusader in diabesity? -- Old and new anti-obesity devices for medical, surgical, and endoscopical use -- Electroceutical approaches for gastroparesis -- Useful Online Resources Hosting Information on Obesity and Diabetes.